Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 467

1.

Osteoarthritis Preoperative Package for care of Orthotics, Rehabilitation, Topical and oral agent Usage and Nutrition to Improve ouTcomes at a Year (OPPORTUNITY); a feasibility study protocol for a randomised controlled trial.

Simpson AHRW, Bell-Higgs A, Conaghan PG, Craig P, Hamilton DF, Hankey C, Keerie C, Kingsbury SR, Kinsella E, Leeds AR, Norrie J, Pandit HG, Ross HM, Simpson SA, Tuck C.

Trials. 2020 Feb 19;21(1):209. doi: 10.1186/s13063-019-3709-5.

2.

Prospects for Therapies in Osteoarthritis.

Ghouri A, Conaghan PG.

Calcif Tissue Int. 2020 Feb 13. doi: 10.1007/s00223-020-00672-9. [Epub ahead of print] Review.

PMID:
32055890
3.

Initiating factors for the onset of OA: A systematic review of animal bone and cartilage pathology in OA.

Casper-Taylor ME, Barr AJ, Williams S, Wilcox RK, Conaghan PG.

J Orthop Res. 2020 Jan 24. doi: 10.1002/jor.24605. [Epub ahead of print]

PMID:
31975435
4.

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized, Placebo-Controlled Study.

Conaghan PG, Bowes MA, Kingsbury SR, Brett A, Guillard G, Rizoska B, Sjögren N, Graham P, Jansson Å, Wadell C, Bethell R, Öhd J.

Ann Intern Med. 2019 Dec 31. doi: 10.7326/M19-0675. [Epub ahead of print]

PMID:
31887743
5.

Improving study conduct and data quality in clinical trials of chronic pain treatments: IMMPACT recommendations.

Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, Cowan P, Doyle MK, Edwards RR, Evans SR, Farrar JT, Freeman R, Gilron I, Juge D, Kerns RD, Kopecky EA, McDermott MP, Niebler G, Patel KV, Rauck R, Rice ASC, Rowbotham M, Sessler NE, Simon LS, Singla N, Skljarevski V, Tockarshewsky T, Vanhove GF, Wasan AD, Witter J.

J Pain. 2019 Dec 13. pii: S1526-5900(19)30880-6. doi: 10.1016/j.jpain.2019.12.003. [Epub ahead of print] Review.

PMID:
31843583
6.

Investigating the patient acceptable symptom state cut-offs: longitudinal data from a community cohort using the shoulder pain and disability index.

Tran G, Dube B, Kingsbury SR, Tennant A, Conaghan PG, Hensor EMA.

Rheumatol Int. 2019 Dec 3. doi: 10.1007/s00296-019-04486-3. [Epub ahead of print]

7.

Time to modify the DAS28 to make it fit for purpose(s) in rheumatoid arthritis?

Hensor EMA, Conaghan PG.

Expert Rev Clin Immunol. 2020 Jan;16(1):1-4. doi: 10.1080/1744666X.2019.1697679. Epub 2019 Nov 30. No abstract available.

PMID:
31790310
8.

The prevalence and impact of self-reported foot and ankle pain in the over 55 age group: a secondary data analysis from a large community sample.

Keenan AM, Drake C, Conaghan PG, Tennant A.

J Foot Ankle Res. 2019 Nov 15;12:53. doi: 10.1186/s13047-019-0363-9. eCollection 2019.

9.

The effects of weight loss on imaging outcomes in osteoarthritis of the hip or knee in people who are overweight or obese: a systematic review.

Daugaard CL, Hangaard S, Bartels EM, Gudbergsen H, Christensen R, Bliddal H, Englund M, Conaghan PG, Boesen M.

Osteoarthritis Cartilage. 2020 Jan;28(1):10-21. doi: 10.1016/j.joca.2019.10.013. Epub 2019 Nov 26. Review.

PMID:
31778811
10.

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial.

Helliwell PS, Coates LC, Chew NS, Lettieri G, Moverley AR, Freeston JE, Nam J, Waxman R, Emery P, Conaghan PG.

J Rheumatol. 2019 Nov 1. pii: jrheum.181385. doi: 10.3899/jrheum.181385. [Epub ahead of print]

PMID:
31676693
11.

Variation in methods, results and reporting in electronic health record-based studies evaluating routine care in gout: A systematic review.

Crossfield SSR, Lai LYH, Kingsbury SR, Baxter P, Johnson O, Conaghan PG, Pujades-Rodriguez M.

PLoS One. 2019 Oct 24;14(10):e0224272. doi: 10.1371/journal.pone.0224272. eCollection 2019.

12.

Very early MRI responses to therapy as a predictor of later radiographic progression in early rheumatoid arthritis.

Conaghan PG, Østergaard M, Troum O, Bowes MA, Guillard G, Wilkinson B, Xie Z, Andrews J, Stein A, Chapman D, Koenig A.

Arthritis Res Ther. 2019 Oct 21;21(1):214. doi: 10.1186/s13075-019-2000-1.

13.

Treating osteoarthritis pain: recent approaches using pharmacological therapies.

Ghouri A, Conaghan PG.

Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):124-129. Epub 2019 Oct 15. Review.

14.

Short-term recovery trajectories of acute flares in knee pain: a UK-Netherlands multi-centre prospective cohort analysis.

Thomas MJ, Yu D, Nicholls E, Bierma-Zeinstra S, Conaghan PG, Stoner KJ, Neogi T, Parry EL, Peat G.

Arthritis Care Res (Hoboken). 2019 Oct 10. doi: 10.1002/acr.24088. [Epub ahead of print]

PMID:
31600034
15.

Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases.

Traylor M, Knevel R, Cui J, Taylor J, Harm-Jan W, Conaghan PG, Cope AP, Curtis C, Emery P, Newhouse S, Patel H, Steer S, Gregersen P, Shadick NA, Weinblatt ME, Van Der Helm-van Mil A, Barrett JH, Morgan AW, Lewis CM, Scott IC.

PLoS One. 2019 Oct 9;14(10):e0223246. doi: 10.1371/journal.pone.0223246. eCollection 2019.

16.

Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early, Poor Prognosis Rheumatoid Arthritis.

Ahmad HA, Baker JF, Østergaard M, Emery P, Durez P, Ye J, Banerjee S, Conaghan PG.

Arthritis Care Res (Hoboken). 2019 Sep 24. doi: 10.1002/acr.24072. [Epub ahead of print]

PMID:
31549793
17.

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.

Coates LC, Mahmood F, Freeston J, Emery P, Conaghan PG, Helliwell PS.

Rheumatology (Oxford). 2019 Aug 31. pii: kez369. doi: 10.1093/rheumatology/kez369. [Epub ahead of print]

PMID:
31504996
18.

Statin Use and Knee Osteoarthritis Outcome Measures according to the Presence of Heberden Nodes: Results from the Osteoarthritis Initiative.

Haj-Mirzaian A, Mohajer B, Guermazi A, Conaghan PG, Lima JAC, Blaha MJ, Bingham CO, Roemer FW, Cao X, Demehri S.

Radiology. 2019 Nov;293(2):396-404. doi: 10.1148/radiol.2019190557. Epub 2019 Sep 10.

PMID:
31502936
19.

Predicting disease progression and poor outcomes in patients with moderately active rheumatoid arthritis: a systematic review.

Edwards CJ, Kiely P, Arthanari S, Kiri S, Mount J, Barry J, Mitchell CR, Field P, Conaghan PG.

Rheumatol Adv Pract. 2019 Feb 15;3(1):rkz002. doi: 10.1093/rap/rkz002. eCollection 2019.

20.

Update on novel pharmacological therapies for osteoarthritis.

Ghouri A, Conaghan PG.

Ther Adv Musculoskelet Dis. 2019 Jul 23;11:1759720X19864492. doi: 10.1177/1759720X19864492. eCollection 2019. Review.

21.

Developing a standardized approach to virtual clinic follow-up of hip and knee arthroplasty.

Preston N, McHugh GA, Hensor EMA, Grainger AJ, O'Connor PJ, Conaghan PG, Stone MH, Kingsbury SR.

Bone Joint J. 2019 Aug;101-B(8):951-959. doi: 10.1302/0301-620X.101B8.BJJ-2018-1566.R1.

PMID:
31362551
22.

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.

Mortimer I, Bissell LA, Hensor EMA, Kozera L, Mackie SL, Burska AN, Nam JL, Keen H, Villeneuve E, Donica H, Buch MH, Conaghan PG, Emery P, Morgan AW, Andrews J.

Rheumatology (Oxford). 2019 Sep 1;58(9):1684-1686. doi: 10.1093/rheumatology/kez114. No abstract available.

23.

Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULAR.

Mandl P, Ciechomska A, Terslev L, Baraliakos X, Conaghan PG, D'Agostino MA, Iagnocco A, van der Laken CJ, Ostergaard M, Naredo E.

RMD Open. 2019 Jun 25;5(2):e000950. doi: 10.1136/rmdopen-2019-000950. eCollection 2019.

24.

Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.

Ahmad HA, Baker JF, Østergaard M, Ye J, Emery P, Conaghan PG.

Adv Ther. 2019 Sep;36(9):2384-2393. doi: 10.1007/s12325-019-01020-6. Epub 2019 Jul 5.

25.

Towards UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for arthroplasty follow-up, and the production of consensus-based recommendations.

Czoski Murray CJ, Kingsbury SR, Arden NK, Hewison J, Judge A, Matu J, O'Shea J, Pinedo-Villanueva R, Smith LK, Smith C, Thomas CM, West RM, Wright JM, Conaghan PG, Stone MH.

BMJ Open. 2019 Jun 25;9(6):e031351. doi: 10.1136/bmjopen-2019-031351.

26.

Toward the Development of Data-Driven Diagnostic Subgroups for People With Patellofemoral Pain Using Modifiable Clinical, Biomechanical, and Imaging Features.

Drew BT, Conaghan PG, Smith TO, Selfe J, Hensor EMA, Dube B, Grainger AJ, Redmond AC.

J Orthop Sports Phys Ther. 2019 Jul;49(7):536-547. doi: 10.2519/jospt.2019.8607. Epub 2019 Jun 18.

PMID:
31213159
27.

Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

Guillemin F, Ricatte C, Barcenilla-Wong A, Schoumacker A, Cross M, Alleyrat C, Buttel T, Cembalo M, Manseur H, Urban H, Fautrel B, Conaghan PG, Hawker G, Rutherford C, March L, Spitz E, Hunter DJ.

J Rheumatol. 2019 Sep;46(9):1188-1191. doi: 10.3899/jrheum.181085. Epub 2019 May 15.

PMID:
31092709
28.

Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis.

Burska AN, Thu A, Parmar R, Bzoma I, Samans B, Raschke E, Olek S, Conaghan PG, Emery P, Ponchel F.

Rheumatology (Oxford). 2019 Nov 1;58(11):2015-2024. doi: 10.1093/rheumatology/kez162.

PMID:
31081041
29.

Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Honvo G, Bannuru RR, Bruyère O, Rannou F, Herrero-Beaumont G, Uebelhart D, Cooper C, Arden N, Conaghan PG, Reginster JY, Thomas T, McAlindon T.

Drugs Aging. 2019 Apr;36(Suppl 1):145-159. doi: 10.1007/s40266-019-00667-8.

30.

Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.

Fuggle N, Curtis E, Shaw S, Spooner L, Bruyère O, Ntani G, Parsons C, Conaghan PG, Corp N, Honvo G, Uebelhart D, Baird J, Dennison E, Reginster JY, Cooper C.

Drugs Aging. 2019 Apr;36(Suppl 1):129-143. doi: 10.1007/s40266-019-00666-9.

31.

Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?

Conaghan PG, Arden N, Avouac B, Migliore A, Rizzoli R.

Drugs Aging. 2019 Apr;36(Suppl 1):7-14. doi: 10.1007/s40266-019-00658-9. Review.

32.

Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms.

Reginster JY, Bruyère O, Conaghan PG, McAlindon T, Cooper C.

Drugs Aging. 2019 Apr;36(Suppl 1):3-6. doi: 10.1007/s40266-019-00659-8. No abstract available.

33.

Therapeutic options for targeting inflammatory osteoarthritis pain.

Conaghan PG, Cook AD, Hamilton JA, Tak PP.

Nat Rev Rheumatol. 2019 Jun;15(6):355-363. doi: 10.1038/s41584-019-0221-y. Review.

34.

Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials.

Kivitz AJ, Conaghan PG, Cinar A, Lufkin J, Kelley SD.

Pain Ther. 2019 Dec;8(2):271-280. doi: 10.1007/s40122-019-0125-1. Epub 2019 May 7.

35.

Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK.

Bray TJP, Jones A, Bennett AN, Conaghan PG, Grainger A, Hodgson R, Hutchinson C, Leandro M, Mandl P, McGonagle D, O'Connor P, Sengupta R, Thomas M, Toms A, Winn N, Hall-Craggs MA, Marzo-Ortega H, Machado PM; British Society of Spondyloarthritis (BRITSpA).

Rheumatology (Oxford). 2019 Oct 1;58(10):1831-1838. doi: 10.1093/rheumatology/kez173.

PMID:
31046100
36.

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

de Wit M, Cooper C, Tugwell P, Bere N, Kirwan J, Conaghan PG, Roberts C, Aujoulat I, Al-Daghri N, Araujo de Carvalho I, Barker M, Bedlington N, Brandi ML, Bruyère O, Burlet N, Halbout P, Hiligsmann M, Jiwa F, Kanis JA, Laslop A, Lawrence W, Pinto D, Prieto Yerro C, Rabenda V, Rizzoli R, Scholte-Voshaar M, Vlaskovska M, Reginster JY.

Aging Clin Exp Res. 2019 Jul;31(7):905-915. doi: 10.1007/s40520-019-01193-8. Epub 2019 Apr 16. Review.

37.

Precision, Reliability, and Responsiveness of a Novel Automated Quantification Tool for Cartilage Thickness: Data from the Osteoarthritis Initiative.

Bowes MA, Guillard GA, Vincent GR, Brett AD, Wolstenholme CBH, Conaghan PG.

J Rheumatol. 2020 Feb;47(2):282-289. doi: 10.3899/jrheum.180541. Epub 2019 Apr 15.

PMID:
30988122
38.

Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.

Langworthy MJ, Conaghan PG, Ruane JJ, Kivitz AJ, Lufkin J, Cinar A, Kelley SD.

Adv Ther. 2019 Jun;36(6):1398-1411. doi: 10.1007/s12325-019-00944-3. Epub 2019 Apr 9.

39.

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

Chiarotto A, Kaiser U, Choy E, Christensen R, Conaghan PG, Cowern M, Gill M, de Wit M, Gargon E, Horgan B, Kirkham JJ, Simon LS, Singh JA, Tugwell P, Turk DC, Mease PJ.

J Rheumatol. 2019 Oct;46(10):1355-1359. doi: 10.3899/jrheum.181099. Epub 2019 Apr 1.

PMID:
30936284
40.

Corticosteroids and osteoarthritis progression: a confounded issue.

Conaghan PG.

Osteoarthritis Cartilage. 2019 Jun;27(6):e5-e6. doi: 10.1016/j.joca.2019.02.799. Epub 2019 Mar 18. No abstract available.

PMID:
30898622
41.

The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example.

Terslev L, Naredo E, Keen HI, Bruyn GAW, Iagnocco A, Wakefield RJ, Conaghan PG, Maxwell LJ, Beaton DE, Boers M, D'Agostino MA.

J Rheumatol. 2019 Oct;46(10):1394-1400. doi: 10.3899/jrheum.181158. Epub 2019 Mar 15.

PMID:
30877208
42.

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.

Maynard C, Mikuls TR, Cannon GW, England BR, Conaghan PG, Østergaard M, Baker DG, Kerr G, George MD, Barton JL, Baker JF.

Arthritis Care Res (Hoboken). 2020 Mar;72(3):326-333. doi: 10.1002/acr.23873.

PMID:
30875461
43.

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Hensor EMA, McKeigue P, Ling SF, Colombo M, Barrett JH, Nam JL, Freeston J, Buch MH, Spiliopoulou A, Agakov F, Kelly S, Lewis MJ, Verstappen SMM, MacGregor AJ, Viatte S, Barton A, Pitzalis C, Emery P, Conaghan PG, Morgan AW.

Rheumatology (Oxford). 2019 Mar 1. pii: kez049. doi: 10.1093/rheumatology/kez049. [Epub ahead of print]

44.

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

Smith TO, Mansfield M, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):976-980. doi: 10.3899/jrheum.181066. Epub 2019 Mar 1.

PMID:
30824657
45.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

46.

Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS).

Sundin U, Østergaard M, Glinatsi D, Aga AB, Hørslev-Petersen K, Hetland ML, Stengard-Pedersen K, Junker P, Ejbjerg BJ, Bird P, Conaghan PG, Lillegraven S, Haavardsholm EA.

J Rheumatol. 2019 Sep;46(9):1222-1227. doi: 10.3899/jrheum.181064. Epub 2019 Feb 15.

PMID:
30770509
47.

Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE).

Krabbe S, Eshed I, Gandjbakhch F, Pedersen SJ, Bird P, Mathew AJ, Lambert RG, Maksymowych WP, Glinatsi D, Stoenoiu MS, Poggenborg R, Jans L, Jaremko JL, Herregods N, Foltz V, Conaghan PG, Althoff CE, Paschke J, Peterfy C, Hermann KA, Østergaard M; for the OMERACT MRI in Arthritis Working Group.

J Rheumatol. 2019 Sep;46(9):1215-1221. doi: 10.3899/jrheum.181084. Epub 2019 Feb 15.

48.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

49.

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ).

Otobo TM, Conaghan PG, Maksymowych WP, van der Heijde D, Weiss P, Sudol-Szopinska I, Herregods N, Jaremko JL, Meyers AB, Rumsey D, Inarejos EC, Kirkhus E, Stimec J, Panwar J, Thorpe K, Jans L, van Rossum MA, Tolend M, Perez M, Tzaribachev N, Sandhya P, Tse S, Simone A, Swami VG, Touma Z, Lambert R, Doria AS.

J Rheumatol. 2019 Sep;46(9):1192-1197. doi: 10.3899/jrheum.181115. Epub 2019 Feb 15.

50.

Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study.

Alten R, Conaghan PG, Strand V, Sullivan E, Blackburn S, Tian H, Gandhi K, Jugl SM, Deodhar A.

Clin Rheumatol. 2019 Jun;38(6):1615-1626. doi: 10.1007/s10067-019-04446-z. Epub 2019 Feb 4.

Supplemental Content

Loading ...
Support Center